Sam Brusco, Associate Editor11.15.22
Neocis, a firm focused on robot-assisted dental implant surgery, has gained U.S. Food and Drug Administration (FDA) clearance of its Yomi system for guided bone reduction.
Tomi assists clinicians in planning and operative phases of dental implant placement via interactive digital planning and physical guidance of surgical instrumentation. The Yomi robot has been used in placement of over 21,000 implants and 850+ full-arch cases since launch.
The new indication allows robot-guided alveoloplasty of the mandible and/or maxilla to help take on complicated full-arch cases. A CT scan is used to digitally plan bone reduction and implant placement. During a procedure, Yomi’s guide arm offers haptic feedback to keep the burr from deviating beyond pre-planned resection boundaries .
With robot-assisted bone reduction, clinicians can freely visualize, irrigate, and palpate the surgical site and modify their treatment plan intraoperatively without sacrificing accuracy.
“Not only does this allow implant clinicians to tackle full-arch restoration with a whole new level of accuracy and confidence, it pushes robot-assisted dental surgery into exciting new territory,” Alon Mozes, Neocis co-founder and CEO told the press. “This clearance is one of our most significant yet, as dental professionals can now use Yomi to perform truly volumetric 3D surgery.”
Ridge reduction involves flattening the surface of a patient’s alveolar bone to create a stable foundation for multiple implants, which are used to anchor a full-arch prosthesis.
“Neocis continues to push the limits of implant dentistry, and Yomi’s new bone reduction functionality is a clear testament to that,” said Dr. Donald Nikchevich, an oral and maxillofacial surgeon based in Southern California and Yomi Diamond Doctor of Excellence. “As someone who performs full-arch rehabilitation regularly, I’m excited to be able to execute ridge reduction with the accuracy, efficiency, and confidence that surgical robotics affords.”
Tomi assists clinicians in planning and operative phases of dental implant placement via interactive digital planning and physical guidance of surgical instrumentation. The Yomi robot has been used in placement of over 21,000 implants and 850+ full-arch cases since launch.
The new indication allows robot-guided alveoloplasty of the mandible and/or maxilla to help take on complicated full-arch cases. A CT scan is used to digitally plan bone reduction and implant placement. During a procedure, Yomi’s guide arm offers haptic feedback to keep the burr from deviating beyond pre-planned resection boundaries .
With robot-assisted bone reduction, clinicians can freely visualize, irrigate, and palpate the surgical site and modify their treatment plan intraoperatively without sacrificing accuracy.
“Not only does this allow implant clinicians to tackle full-arch restoration with a whole new level of accuracy and confidence, it pushes robot-assisted dental surgery into exciting new territory,” Alon Mozes, Neocis co-founder and CEO told the press. “This clearance is one of our most significant yet, as dental professionals can now use Yomi to perform truly volumetric 3D surgery.”
Ridge reduction involves flattening the surface of a patient’s alveolar bone to create a stable foundation for multiple implants, which are used to anchor a full-arch prosthesis.
“Neocis continues to push the limits of implant dentistry, and Yomi’s new bone reduction functionality is a clear testament to that,” said Dr. Donald Nikchevich, an oral and maxillofacial surgeon based in Southern California and Yomi Diamond Doctor of Excellence. “As someone who performs full-arch rehabilitation regularly, I’m excited to be able to execute ridge reduction with the accuracy, efficiency, and confidence that surgical robotics affords.”